Revium Rx (RVRC) Cash & Current Investments (2024 - 2025)
Revium Rx's (RVRC) quarterly Cash & Current Investments came in at $2.7 million in Q4 2025, down 48.65% year-on-year from $5.3 million in Q4 2024, and down 48.65% quarter-over-quarter from $5.3 million in Q4 2024.
Revium Rx (RVRC) Cash & Current Investments (2024 - 2025) Analysis & Trends
Revium Rx has disclosed Cash & Current Investments across 2 years of filings, most recently posting $2.7 million for Q4 2025.
- Cash & Current Investments for Q4 2025 came in at $2.7 million, down 48.65% year-over-year; the trailing twelve-month figure through Dec 2025 was $2.7 million (down 48.65% YoY), and the FY2025 annual result was $2.7 million, down 48.65% from the prior year.
- Cash & Current Investments came in at $2.7 million for Q4 2025 at Revium Rx, down from $5.3 million in the prior quarter.
- In the past five years, Cash & Current Investments ranged from a high of $5.3 million in Q4 2024 to a low of $2.7 million in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Veeva Systems | 24.83 Bn | 17.52 Bn | 662.02 Mn | 7.31 Bn |
| 2 | BrightSpring Health Services | 13.57 Bn | 12.69 Bn | 482.22 Mn | 888.80 Mn |
| 3 | Healthequity | 7.20 Bn | 6.93 Bn | 256.31 Mn | 265.37 Mn |
| 4 | Hinge Health | 5.42 Bn | 5.11 Bn | 154.23 Mn | 315.87 Mn |
| 5 | 10x Genomics | 4.46 Bn | 3.92 Bn | 106.18 Mn | 539.85 Mn |
| 6 | Doximity | 3.81 Bn | 3.06 Bn | 125.97 Mn | 748.60 Mn |
| 7 | Waystar Holding | 3.52 Bn | 3.36 Bn | 268.04 Mn | 158.93 Mn |
| 8 | Privia Health | 2.94 Bn | 2.57 Bn | 595.71 Mn | 419.52 Mn |
| 9 | Omnicell | 1.76 Bn | 1.59 Bn | 140.36 Mn | 174.90 Mn |
| 10 | Revium Rx | - | - | - | 2.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 2.71 Mn |
| Dec 31, 2024 | 5.28 Mn |